A CDC Panel Backs Booster Shots For Older Adults, A Step Toward Making Them Available
The advisory committee's recommendation follows the FDA's authorization of Pfizer vaccine boosters for people 65 and up. Both regulatory moves will inform the U.S. plan to dispense extra doses.
Updated September 23, 2021 at 5:14 PM ET
Advisers to the Centers for Disease Control and Prevention have recommended a third dose of Pfizer's COVID-19 vaccine for people 65 and older as well as others at a high risk of severe illness.
The committee's unanimous vote to allow older adults and long-term care residents to receivean extra dose of thereviewing scientific evidence on the safety and effectiveness of a third vaccine dose.
